tetradecanoylphorbol acetate has been researched along with aspalathin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JS; Han, MS; Kwak, S | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and aspalathin
| Article | Year |
|---|---|
Aspalathin and nothofagin from rooibos (Aspalathus linearis) inhibit endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Aspalathus; Blood Coagulation Factors; Chalcones; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; Male; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2015 |